Published in Alcohol Clin Exp Res on November 01, 1996
Alcohol: effects on neurobehavioral functions and the brain. Neuropsychol Rev (2007) 2.20
Neuroinflammation as a neurotoxic mechanism in alcoholism: commentary on "Increased MCP-1 and microglia in various regions of human alcoholic brain". Exp Neurol (2008) 0.93
Synthesis-free PET imaging of brown adipose tissue and TSPO via combination of disulfiram and (64)CuCl2. Sci Rep (2017) 0.75
Tracing European founder lineages in the Near Eastern mtDNA pool. Am J Hum Genet (2000) 7.06
Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. Brain (2008) 6.29
A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med (1995) 4.44
DIHYDROXYACETONE STUDIES: I. Its Respiratory and Carbohydrate Metabolism in Normal Men. J Clin Invest (1926) 4.32
Relationships between biomarkers in aging and dementia. Neurology (2009) 4.16
DIHYDROXYACETONE STUDIES: II. Its Respiratory and Carbohydrate Metabolism in Diabetes Mellitus. J Clin Invest (1926) 3.75
Age differences in the frontal lateralization of verbal and spatial working memory revealed by PET. J Cogn Neurosci (2000) 3.66
Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science (2001) 3.48
Spatial working memory in humans as revealed by PET. Nature (1993) 3.42
Life quality of patients with chronic obstructive pulmonary disease. Arch Intern Med (1982) 3.30
Dissociating verbal and spatial working memory using PET. Cereb Cortex (1996) 3.18
Verbal Working Memory Load Affects Regional Brain Activation as Measured by PET. J Cogn Neurosci (1997) 3.00
Inhibition in verbal working memory revealed by brain activation. Proc Natl Acad Sci U S A (1998) 3.00
The role of parietal cortex in verbal working memory. J Neurosci (1998) 2.89
Anatomic standardization: linear scaling and nonlinear warping of functional brain images. J Nucl Med (1994) 2.76
Frequency of symptomatic and asymptomatic herpes simplex virus type 2 reactivations among human immunodeficiency virus-infected men. J Infect Dis (1998) 2.72
Complete sequence of the Rous sarcoma virus env gene: identification of structural and functional regions of its product. J Virol (1983) 2.53
Brain activation in PTSD in response to trauma-related stimuli. Biol Psychiatry (1999) 2.38
Chemotherapy response criteria in malignant glioma. Neurology (1997) 2.32
Treatment of Wilson's disease with zinc. XVII: treatment during pregnancy. Hepatology (2000) 2.31
Clinical comparison of a new automated infrared blood culture system with the BACTEC 460 system. J Clin Microbiol (1986) 2.28
Components of verbal working memory: evidence from neuroimaging. Proc Natl Acad Sci U S A (1998) 2.15
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas. Lancet Oncol (2011) 2.13
Neuropsychologic findings in hypoxemic chronic obstructive pulmonary disease. Arch Intern Med (1982) 2.06
Imaging the brain. First of two parts. N Engl J Med (1998) 2.03
Imaging the brain. Second of two parts. N Engl J Med (1998) 2.02
History of falls in Parkinson disease is associated with reduced cholinergic activity. Neurology (2009) 2.01
Polypeptide conformation of cytoplasmic malate dehydrogenase from an electron density map at 3.0 angstrom resolution. J Mol Biol (1972) 1.94
Automated detection of the intercommissural line for stereotactic localization of functional brain images. J Nucl Med (1993) 1.93
Degree of inhibition of cortical acetylcholinesterase activity and cognitive effects by donepezil treatment in Alzheimer's disease. J Neurol Neurosurg Psychiatry (2005) 1.89
Spontaneous intracranial hypotension causing reversible frontotemporal dementia. Neurology (2002) 1.89
Spatial versus Object Working Memory: PET Investigations. J Cogn Neurosci (1995) 1.88
In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease. Neurology (1999) 1.86
The extinction of a self-injurious behavior in an epileptic child. Behav Res Ther (1973) 1.84
Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients. J Infect Dis (1998) 1.83
Cerebral cortical and subcortical cholinergic deficits in parkinsonian syndromes. Neurology (2010) 1.79
Age differences in behavior and PET activation reveal differences in interference resolution in verbal working memory. J Cogn Neurosci (2000) 1.76
Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype? Arterioscler Thromb Vasc Biol (2001) 1.76
Day hospital versus admission for acute psychiatric disorders. Cochrane Database Syst Rev (2003) 1.75
Limited donepezil inhibition of acetylcholinesterase measured with positron emission tomography in living Alzheimer cerebral cortex. Ann Neurol (2000) 1.73
Analysis of covariance as a remedy for demographic mismatch of research subject groups: some sobering simulations. J Clin Exp Neuropsychol (1985) 1.66
Comparison of bacterial isolation, cytotoxicity assay, and counterimmunoelectrophoresis for the detection of Clostridium difficile and its toxin. J Infect Dis (1983) 1.57
Fertility preservation in cancer survivors: a national survey of oncologists' current knowledge, practice and attitudes. Br J Cancer (2013) 1.57
Psychologic effects of continuous and nocturnal oxygen therapy in hypoxemic chronic obstructive pulmonary disease. Arch Intern Med (1983) 1.55
Initial therapy of patients with Wilson's disease with tetrathiomolybdate. Arch Neurol (1991) 1.53
Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels. Am J Psychiatry (1998) 1.48
A comparison of cerebral blood flow and glucose metabolism in olivopontocerebellar atrophy using PET. Neurology (1995) 1.47
Brain lesions and cognitive function in late-life psychosis. Br J Psychiatry (1991) 1.46
In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease. Ann Neurol (1996) 1.45
Comparison of human cerebral activation pattern during cutaneous warmth, heat pain, and deep cold pain. J Neurophysiol (1996) 1.42
Neuropsychological changes in olivopontocerebellar atrophy. Arch Neurol (1990) 1.42
The relationship of multiple system atrophy to sporadic olivopontocerebellar atrophy and other forms of idiopathic late-onset cerebellar atrophy. Neurology (1996) 1.41
Treatment of Wilson's disease with zinc: XV long-term follow-up studies. J Lab Clin Med (1998) 1.40
Isolation of specific interference processing in the Stroop task: PET activation studies. Neuroimage (1997) 1.40
Concurrent treatment of patients with depression in the community: provider practices, attitudes, and barriers to collaboration. J Fam Pract (1999) 1.39
Quality of life during chemotherapy for small cell lung cancer: assessment and use of a daily diary card in a randomized trial. Eur J Cancer (1990) 1.37
Dual-task effects of talking while walking on velocity and balance following a stroke. Age Ageing (2001) 1.37
Xestospongin C is an equally potent inhibitor of the inositol 1,4,5-trisphosphate receptor and the endoplasmic-reticulum Ca(2+) pumps. Cell Calcium (2000) 1.35
Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging. Ann Neurol (1996) 1.35
Decreased striatal dopaminergic innervation in REM sleep behavior disorder. Neurology (2000) 1.33
The neural basis of task-switching in working memory: effects of performance and aging. Proc Natl Acad Sci U S A (2001) 1.30
Neurotoxicity of radiological contrast agents. Ann Neurol (1983) 1.29
Limbic activation and psychophysiologic responses to aversive visual stimuli. Interaction with cognitive task. Neuropsychopharmacology (2000) 1.28
Neuropsychological deficits are correlated with frontal hypometabolism in positron emission tomography studies of older alcoholic patients. Alcohol Clin Exp Res (1993) 1.27
"Anatometabolic" tumor imaging: fusion of FDG PET with CT or MRI to localize foci of increased activity. J Nucl Med (1993) 1.26
Treatment of Wilson's disease with zinc XVI: treatment during the pediatric years. J Lab Clin Med (2001) 1.26
Stereotactic PET atlas of the human brain: aid for visual interpretation of functional brain images. J Nucl Med (1994) 1.25
Public health implications of the microbial pesticide Bacillus thuringiensis: an epidemiological study, Oregon, 1985-86. Am J Public Health (1990) 1.24
Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care. Health Technol Assess (2001) 1.23
Clinical outcome in aggressively treated meningeal carcinomatosis. Arch Neurol (1994) 1.21
Positron emission tomographic analysis of cerebral structures activated specifically by repetitive noxious heat stimuli. J Neurophysiol (1994) 1.20
PET evidence for an amodal verbal working memory system. Neuroimage (1996) 1.19
The effect of emotional content on visual recognition memory: a PET activation study. Neuroimage (1998) 1.19
Letter: Molecular symmetry axes and subunit interfaces in certain dehydrogenases. J Mol Biol (1973) 1.18
Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET. J Nucl Med (1996) 1.18
Increased ventral striatal monoaminergic innervation in Tourette syndrome. Neurology (2003) 1.18
Mechanism of action of 1-beta-D-2,6-diaminopurine dioxolane, a prodrug of the human immunodeficiency virus type 1 inhibitor 1-beta-D-dioxolane guanosine. Antimicrob Agents Chemother (2001) 1.17
Response of the μ-opioid system to social rejection and acceptance. Mol Psychiatry (2013) 1.15
Imaging the vesicular monoamine transporter. Adv Neurol (2001) 1.15
Cerebellar and frontal hypometabolism in alcoholic cerebellar degeneration studied with positron emission tomography. Ann Neurol (1990) 1.15
Progressive neuropsychologic impairment and hypoxemia. Relationship in chronic obstructive pulmonary disease. Arch Gen Psychiatry (1987) 1.15
Nicotine effects on regional cerebral blood flow in awake, resting tobacco smokers. Synapse (2000) 1.09
Vesicular monoamine transporter concentrations in bipolar disorder type I, schizophrenia, and healthy subjects. Biol Psychiatry (2001) 1.08
Performance comparison of parameter estimation techniques for the quantitation of local cerebral blood flow by dynamic positron computed tomography. J Cereb Blood Flow Metab (1985) 1.07
PET of peripheral benzodiazepine binding sites in the microgliosis of Alzheimer's disease. J Nucl Med (1995) 1.07
Comparison of CAGE questionnaire and computer-assisted laboratory profiles in screening for covert alcoholism. Lancet (1990) 1.07
Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia. Neuropsychopharmacology (1999) 1.06
REM sleep behavior disorder is related to striatal monoaminergic deficit in MSA. Neurology (2003) 1.06
Effects of nicotine on regional cerebral glucose metabolism in awake resting tobacco smokers. Neuroscience (2000) 1.06
Regional cerebral blood flow effects of nicotine in overnight abstinent smokers. Biol Psychiatry (2001) 1.04
Predictors of comorbid alcohol and substance abuse in depressed adolescents. J Am Acad Child Adolesc Psychiatry (1996) 1.03